CNXU
Conexeu Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.54
−10.25%Oct 28, 2026, 07:10 UTC
Conexeu Sciences Inc. offered inducement warrants to holders of existing warrants, exercisable for one common share at $3.00 per share for 24 months, in exchange for early exercise of existing warrants.
Oct 15, 2026, 20:30 UTC
Conexeu Sciences Inc. announced a $5 million private placement led by existing shareholders, management and directors, with participation from its CEO and Chief Commercial Officer.
Source:Oct 6, 2026, 12:30 UTC
Conexeu Sciences Inc. provided an update on its regulatory and manufacturing program supporting a planned FDA 510(k) premarket notification for its lead wound care device candidate Ten Minute Tissue.
Source:Sep 10, 2026, 20:32 UTC
Conexeu Sciences Inc. issued 762,608 shares of common stock at $2.30 per share to one individual and three entities upon exercise of warrants, raising $1,753,998.40 under Regulation D and Regulation S.
Jun 9, 2026, 00:00 UTC
Conexeu Sciences Inc. issued 416,667 shares of common stock and 416,667 incentive warrants upon exercise of outstanding warrants under its warrant exercise incentive program, raising approximately $166,667 in gross proceeds on June 4, 2026.
May 15, 2026, 00:00 UTC
Conexeu Sciences Inc. issued 4,342,648 shares of common stock upon the exercise of warrants under its Warrant Exercise Incentive Program, raising approximately $1,963,967 in aggregate gross proceeds on May 12, 2026.